Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03179956Early Phase 1Terminated
Impact of Ribociclib on Head and Neck Squamous Cell Cancer
Squamous Cell Carcinoma of the Head and Neck
PrincipalinvestigatorStart date: 2018-04-02
NCT01316757Phase 2Completed
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+20 more
PrincipalinvestigatorStart date: 2011-02-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Anurag Singh

Roswell Park Cancer Institute

Related
10 trials

Shared therapeutic areas:

Stage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the NasopharynxRecurrent Squamous Cell Carcinoma of the Hypopharynx+13 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Tongue
Similarity Score3%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Dan Zandberg, MD

UPMC Hillman Cancer Center

Related
6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Ezra Cohen, MD

University of Chicago

Related
6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Ari Rosenberg, MD

University of Chicago

Related
5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Jared Weiss, MD

University of North Carolina, Chapel Hill

Related
7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Amar Patel, MD

Celgene

Related
5 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Anna Spreafico, MD

Princess Margaret Cancer Centre

Related
6 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03179956Early Phase 1PrincipalInvestigator

Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Squamous Cell Carcinoma of the Head and Neck
Terminated
NCT01316757Phase 2PrincipalInvestigator

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+20 more
Completed

All 2 trials loaded